Señora, Charylette B.

HRN: 02-92-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/11/2025
08/18/2025
IV
1.5g
Q8hrs
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: